公司資料
Windtree Therapeutics 股價、新聞與催化劑
- 股票代碼:
- WINT
- 交易所:
- NASDAQ
- 產業:
- MedTech
- 所在地:
- United States
股票表現
0.00 USD (0.00%)
收盤價
最後更新: 2026年8月24日
—
市值
股價為何變動
As of Aug 24, 2026, WINT was little changed and closed at $0.0001. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
Windtree Therapeutics is a specialty pharmaceutical company focused on respiratory and acute-care therapies, with a history of working on surfactant-based and other hospital-oriented programs. Its business has often been shaped by a narrow pipeline and strategic repositioning.
所在地與產業分類
Windtree is headquartered in the United States and listed on NASDAQ. It sits in specialty pharma and respiratory therapeutics.
商業模式特徵
The company depends on clinical progress, corporate strategy, and financing to keep a limited set of programs moving. Investors watch updates on pipeline direction and the company's ability to preserve value in a difficult market.
生技產業定位
Windtree occupies a small respiratory-specialty niche within biotech-adjacent pharma. The stock is usually driven by whether the company can create a clear, fundable development thesis.
未來催化劑
- Windtree’s catalysts are respiratory and critical-care product updates, plus any strategic or financing step that supports the company’s next phase. The stock remains sensitive to execution and capital.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。